Registered entities
Exo Therapeutics, Inc.
Reg. No. 83-2161055United States
Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 9 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
Social engagement
Social engagement: 4.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Nextech Invest, Novartis Venture Fund, CRV, Newpath Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 2 | 22% |
Recent activity
24 Feb 2026
Event
Global Life Science Partnering & Investor Conference
5 Feb 2026
Event
Global Life Science Partnering & Investor Conference
23 Jan 2026
Recognition